Pepsi's earnings per share in the second quarter were $1.70, compared with market expectations of $1.52 and $1.18 in the same period last year.
Pepsi's earnings per share in the second quarter were $1.70, compared with market expectations of $1.52 and $1.18 in the same period last year.
This text is a result of machine translation.
Related companies：
Briefing Oct 27, 2023 08:24 AM
· Consumer Staples
Anjoy Foods Q3 Net Profit Totaled CNY 386 million, with an Impressive YoY Increase of 63.75%
Briefing Sep 23, 2023 01:43 AM
· Consumer Staples
China's Outbound Non-financial Direct Investment Increased 18.8% YoY
In-depth
Consumer Staples
Chinese Restaurant Brands Going Global: What Keeps Customers Coming Back After the Opening?
How long can the queues outside a brand’s first overseas store last? And how many customers drawn in by the novelty will become regulars? For Chinese restaurant brands expanding internationally, opening a store is only the beginning of the challenge of building a local business and retaining customers.
Sep 09, 2026 02:48 PM
Briefing May 23, 2022 11:54 AM
· Consumer Staples
The Civil Aviation Administration issued a public air transport enterprise business license for Jiangsu Jingdong Cargo Airlines Co., Ltd. (Preparatory)
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Briefing May 21, 2022 09:59 AM
· Consumer Staples
Maotai Group: it will carry out in-depth cooperation with Mengniu Group in ice cream and other fields
Briefing Jan 28, 2022 07:29 PM
· Consumer Staples
Ganfeng lithium industry: signed the strategic framework agreement with the people's Government of Haixi Prefecture, Qinghai Province
Consumer Staples
SHEIN Expands Polish Logistics Hub with EUR 500 Million Investment
SHEIN（希音）announced a further EUR 500 million investment to expand its European logistics hub near Wrocław, Poland. The company said the investment would bring its cumulative spending in Poland since 2022 to EUR 1 billion and support faster order fulfilment across Europe.
Nov 05, 2026 11:38 AM
Healthcare
Sino Biopharm and Boehringer Ingelheim Sign Option and License Deal for Six Cancer Programs
Sino Biopharmaceutical（中国生物制药）and Boehringer Ingelheim（勃林格殷格翰）announced an option and license agreement on November 4 covering six preclinical cancer programs. Sino Biopharm will receive USD 358 million in upfront and near-term payments and may receive up to USD 7 billion in additional option, development, regulatory and commercial milestone payments.
Nov 05, 2026 11:22 AM
Briefing Dec 06, 2021 01:19 PM
· Consumer Staples
MSCI's rating was upgraded and Mengniu's ESG rating was upgraded to "BBB"
Briefing Aug 25, 2021 10:58 PM
Mengniu Dairy: revenue of 45.91 billion yuan and net profit of 2.95 billion yuan in the first half of the year
Briefing Jul 07, 2021 12:02 AM
· Consumer Staples
China Shengmu: wholly owned subsidiary of China Mengniu increases 12.48% of the company's shares
Briefing Nov 20, 2020 04:33 PM
· Consumer Staples
CICC: Mengniu's medium-term operating profit margin may be improved to maintain the "outperforming industry" rating
Briefing Aug 27, 2020 09:58 AM
· Consumer Staples
Mengniu Dairy: Revenue Falls 5.80% YoY to CNY 37.53 Billion in 1H 2020
See more
Read next
Insight
In-depth
AI · Analysis
Revenue Up 283%, Over 60% From Overseas: MiniMax's Global Expansion
Nov 05, 2026 08:41 PM
Insight
In-depth
Mobility · Analysis
How BYD Is Turning China's EV Advantages into Global Growth
Nov 05, 2026 08:35 PM
Insight
In-depth
Embodied AI · Analysis
Capital Has No Passport - In an Age of Economic Sovereignty, how to position “China” in European Capital Markets?
Oct 21, 2026 04:46 PM
Insight
In-depth
Technology · Analysis
Which Way Is the Wind Blowing? How to Balance Geopolitics and Heavy Capex Investment
Oct 08, 2026 05:15 PM